Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00JAH
|
|||
Drug Name |
PMID27841036-Compound-24
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
Janssen Pharmaceutica NV
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H20N4O
|
|||
Canonical SMILES |
CC(CC1=NC(=CC=C1)C#N)(C#N)C2=CC3=C(C=C2)C4=C(CCCC4)C(=O)N3
|
|||
InChI |
1S/C23H20N4O/c1-23(14-25,12-16-5-4-6-17(13-24)26-16)15-9-10-19-18-7-2-3-8-20(18)22(28)27-21(19)11-15/h4-6,9-11H,2-3,7-8,12H2,1H3,(H,27,28)
|
|||
InChIKey |
WVGLSASLDWFLFS-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Poly [ADP-ribose] polymerase (PARP) | Target Info | Inhibitor | [1] |
Target's Patent Info | Poly [ADP-ribose] polymerase (PARP) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | PARP inhibitors as antitumor agents: a patent update (2013-2015).Expert Opin Ther Pat. 2017 Mar;27(3):363-382. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.